Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

Clinical trial NCT01266057 · COMPLETED

Trial details

NCT number: NCT01266057
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2011-04-28
Primary completion: 2021-02-11
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.